Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer | MicrobiomeTrials
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-06-10Est. Completion: 2028-01-10
Enrollment target: 70 participants
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States